Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
European Archives of Psychiatry and Clinical Neuroscience|August 29, 2024
Advancing past ketamine: emerging glutamatergic compounds for the treatment of depressionFlorian Freudenberg, Christine Reif-Leonhard, Andreas Reif
Pharmacological Research|August 21, 2025
All roads lead to glutamate: NMDA and AMPA receptors as targets for rapid-acting antidepressantsFlorian Freudenberg, Christine Reif-Leonhard, Gerard R Dawson, et al.
Clinical Drug Investigation|February 27, 2019
The Combination of Lithium and ACE Inhibitors: Hazardous, Critical, Possible?Leif Hommers, Matthias Fischer, Christine Reif-Leonhard, et al.
Frontiers in Psychiatry|October 16, 2023
Impact of COVID-19 on the treatment of depressive patients in Germany-a gap in care for the mentally ill?Mareike Aichholzer, Carmen Schiweck, Carmen Uckermark, et al.
Journal of Affective Disorders|February 28, 2025
Titration of vagus nerve stimulation for difficult-to-treat depression and onset of response: Early insights from the RESTORE-LIFE studyErhan Kavakbasi, Christoph Kraus, Christine Reif-Leonhard, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 12, 2026
Population-based prevalence and pharmacotherapy sequences of treatment resistant depression in GermanyMaximilian A Bayas, Jeffrey Auerbach, Bettina Diekamp, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 7, 2025
Effects of repeated intravenous esketamine administration on affective biasesChristine Reif-Leonhard, Shannon N Millard, Dorsa Ferdowssian, et al.
Journal of Affective Disorders|July 1, 2026
Transcutaneous vagus nerve stimulation enhances reward-effort efficiency in severe major depressive disorderPaul A G Forbes, Emily Brandt, Mareike Aichholzer, et al.
Pageof 2